These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21184997)

  • 1. Effect of insurance type on adverse cardiac events after percutaneous coronary intervention.
    Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Ben-Dor I; Maluenda G; Mahmoudi M; Sardi G; Wakabayashi K; Kaneshige K; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2011 Mar; 107(5):675-80. PubMed ID: 21184997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insurance type influences the use of drug-eluting stents.
    Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Collins SD; Ben-Dor I; Syed AI; Maluenda G; Delhaye C; Hanna N; Wakabayashi K; Kaneshige K; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    JACC Cardiovasc Interv; 2010 Jul; 3(7):773-9. PubMed ID: 20650440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention.
    Parikh PB; Gruberg L; Jeremias A; Chen JJ; Naidu SS; Shlofmitz RA; Brener SJ; Pappas T; Marzo KP; Brown DL
    Am Heart J; 2011 Sep; 162(3):512-7. PubMed ID: 21884869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
    Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.
    Glaser R; Selzer F; Jacobs AK; Laskey WK; Kelsey SF; Holper EM; Cohen HA; Abbott JD; Wilensky RL
    Am J Cardiol; 2006 Dec; 98(11):1446-50. PubMed ID: 17126647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
    Ayanian JZ; Kohler BA; Abe T; Epstein AM
    N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
    D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
    Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal health insurance coverage does not eliminate inequities in access to cardiac procedures after acute myocardial infarction.
    Pilote L; Joseph L; Bélisle P; Penrod J
    Am Heart J; 2003 Dec; 146(6):1030-7. PubMed ID: 14660995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction.
    Chen LY; Lennon RJ; Grantham JA; Berger PB; Mathew V; Singh M; Holmes DR; Rihal CS
    Am J Cardiol; 2005 Feb; 95(3):349-54. PubMed ID: 15670543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Tjandrawidjaja MC; Fu Y; Westerhout CM; Wagner GS; Granger CB; Armstrong PW;
    Am J Cardiol; 2010 Sep; 106(5):630-4. PubMed ID: 20723636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
    Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Wenaweser P; Ramser M; Windecker S; Lütolf I; Meier B; Seiler C; Eberli FR; Hess OM
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):485-90. PubMed ID: 17894363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years.
    Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1151-6. PubMed ID: 16863605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial).
    Arjomand H; Willerson JT; Holmes DR; Bamlet WR; Surabhi SK; Roukoz B; Espinoza A; McClelland RL; McCormick DJ; Goldberg S;
    Am J Cardiol; 2005 Sep; 96(6):741-6. PubMed ID: 16169350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.